Concepedia

Nora Bayani

NB

Statistics

Publications

14

Citations

4.7K

H-Index

13

Active since

2006

Affiliations

Lawrence Berkeley National Laboratory(Current)

University of California, San Francisco

Oregon Health & Science University

UCSF Helen Diller Family Comprehensive Cancer Center

University of California, Berkeley

Nora Bayani is an author at Lawrence Berkeley National Laboratory specializing in oncology, medicine, and molecular oncology.

Publications per year

2006–2025

14

Publications

14

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Richard M. Neve, Koei Chin, Jane Fridlyand et al. · Cancer Cell · 2006 · 3.2K citations · Full text

, , +14

Subtype and pathway specific responses to anticancer compounds in breast cancer

Laura M. Heiser, Anguraj Sadanandam, Wen‐Lin Kuo et al. · Proceedings of the National Academy of Sciences · 2011 · 504 citations

, , +17

Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition

Olga K. Mirzoeva, Debopriya Das, Laura M. Heiser et al. · Cancer Research · 2009 · 389 citations · Full text

, , +17

The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer

Zhi Hu, Ge Huang, Anguraj Sadanandam et al. · Breast Cancer Research · 2010 · 138 citations · Full text

, , +17

Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer

Hayley Donnella, James T. Webber, Rebecca S. Levin et al. · Nature Chemical Biology · 2018 · 92 citations

, , +11

1–5 of 14